US researchers say teenagers are more likely to get vaccine-related myocarditis than end up in hospital with Covid

US researchers say teenagers are more likely to get vaccine-related myocarditis than end up in hospital with Covid

Case Western Reserve University researchers, in partnership with Brown University, examine COVID-19 vaccine’s effectiveness over time on seniors.

Scientists continued debating the need for a third dose of the vaccines for older Americans, leaving open the possibility of other votes.

This report describes COVID-19 vaccine effectiveness against hospitalizations for all three vaccines, with Moderna as the most effective against hospitalization.

Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects

Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was safe and produced strong antibody responses in children ages 5 to 11 in a large-scale trial, findings that could pave the way to begin vaccinating grade-school kids within months.

The data suggests that the drop is due to waning efficacy, rather than more contagious variants, researchers said.

Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, ...

Studies from Qatar and Israel found Pfizer less effective overall after a few months, but it's very good at fighting off severe disease and death.

Pfizer Inc. and BioNTech SE said a booster shot of their Covid-19 vaccine restored full protection in a large study, results that are likely to bolster the argument for giving a third dose more widely.

An FDA advisory panel voted in favor of authorizing the Pfizer/BioNTech Covid-19 vaccine for children between the ages of 5 and 11.

It’s possible that a good deal of the difference in the shots’ performance can be summed up with a simple phrase: More is better.

Questions arose after the publication of a study from Clalit Health Services in Israel,
in which adverse events from BNT162b2 vaccination and from SARS-CoV-2 infection were
examined. To address the ...

FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.